2023
Lung Cancer Screening Decision Aid Designed for a Primary Care Setting
Schapira M, Hubbard R, Whittle J, Vachani A, Kaminstein D, Chhatre S, Rodriguez K, Bastian L, Kravetz J, Asan O, Prigge J, Meline J, Schrand S, Ibarra J, Dye D, Rieder J, Frempong J, Fraenkel L. Lung Cancer Screening Decision Aid Designed for a Primary Care Setting. JAMA Network Open 2023, 6: e2330452. PMID: 37647070, PMCID: PMC10469267, DOI: 10.1001/jamanetworkopen.2023.30452.Peer-Reviewed Original ResearchConceptsLung cancer screeningPrimary care settingDecisional conflictClinical trialsCare settingsVeterans Affairs Medical CenterDecisional conflict scoresWeb-based patientAttention control interventionFuture implementation strategiesCurrent smokersSecondary outcomesSmoking historyPrimary outcomeCancer screeningRecruitment lettersMedical CenterMAIN OUTCOMEDecisional regretClinical practiceWest HavenControl groupKnowledge scoreControl interventionsLatino ethnicity
2013
Assessment of the Impact of Adjunctive Proactive Telephone Counseling to Promote Smoking Cessation among Lung Cancer Patients' Social Networks
Bastian LA, Fish LJ, Peterson BL, Biddle AK, Garst J, Lyna P, Molner S, Bepler G, Kelley M, Keefe FJ, McBride CM. Assessment of the Impact of Adjunctive Proactive Telephone Counseling to Promote Smoking Cessation among Lung Cancer Patients' Social Networks. American Journal Of Health Promotion 2013, 27: 181-190. PMID: 23286595, DOI: 10.4278/ajhp.101122-quan-387.Peer-Reviewed Original ResearchConceptsProactive telephone counselingCessation ratesPatient's social networkMonths postinterventionTelephone counselingSmoking cessationLung cancerSelf-directed interventionsAdaptive coping skillsCounseling phone callsPoint prevalent abstinenceCoping skillsMotivational interviewing techniquesCurrent smokersCessation effortsCounseling callsIntervention groupWeeks postinterventionArm differencesControl groupClinical sitesPostinterventionSpecial populationsGroup differencesIntervention
2009
Active Mothers Postpartum A Randomized Controlled Weight-Loss Intervention Trial
Østbye T, Krause KM, Lovelady CA, Morey MC, Bastian LA, Peterson BL, Swamy GK, Brouwer RJ, McBride CM. Active Mothers Postpartum A Randomized Controlled Weight-Loss Intervention Trial. American Journal Of Preventive Medicine 2009, 37: 173-180. PMID: 19595557, PMCID: PMC2774935, DOI: 10.1016/j.amepre.2009.05.016.Peer-Reviewed Original ResearchConceptsPhysical activityWeight lossWeight loss intervention trialActive Mothers PostpartumPostpartum weight lossTelephone counseling sessionsImprovement of dietSustainable lifestyle changesHome-based interventionObese womenMothers postpartumSignificant group differencesIntervention trialsObstetric clinicsPostpartum periodIntervention groupIntervention participantsPhysical activity classesLifestyle changesCommunity postersControl groupWeight retentionSecondary analysisIntervention RCTsPostpartum
2008
Promoting Regular Mammography Screening II. Results From a Randomized Controlled Trial in US Women Veterans
Vernon SW, del Junco DJ, Tiro JA, Coan SP, Perz CA, Bastian LA, Rakowski W, Chan W, Lairson DR, McQueen A, Fernandez ME, Warrick C, Halder A, DiClemente C. Promoting Regular Mammography Screening II. Results From a Randomized Controlled Trial in US Women Veterans. Journal Of The National Cancer Institute 2008, 100: 347-358. PMID: 18314474, PMCID: PMC2830858, DOI: 10.1093/jnci/djn026.Peer-Reviewed Original ResearchConceptsHazard rate ratiosPP analysisWomen veteransControl groupMITT analysisOdds ratioMammography coverageCorresponding hazard rate ratiosCox proportional hazards regressionLogistic regressionHealth promotion trialUS women veteransProportional hazards regressionRate ratioHigher mammography ratesRegular mammography screeningTheory-based interventionControlled TrialsCox modelingITT analysisHazards regressionMammography ratesCrude coverageIntervention effect estimatesNational registry
2003
Daytime testing after laboratory or home‐based polysomnography: comparisons of middle‐aged insomnia sufferers and normal sleepers
Edinger JD, Glenn DM, Bastian LA, Marsh GR, Dailey D, Hope TV, Young M, Shaw E, Meeks G. Daytime testing after laboratory or home‐based polysomnography: comparisons of middle‐aged insomnia sufferers and normal sleepers. Journal Of Sleep Research 2003, 12: 43-52. PMID: 12603786, DOI: 10.1046/j.1365-2869.2003.00335.x.Peer-Reviewed Original ResearchConceptsMultiple sleep latency testInsomnia sufferersNormal sleepersDaytime multiple sleep latency testSleep latency testNormal control groupHome-based polysomnographyPersistent primary insomniaLatency testPrimary insomniaNormal controlsReaction time testControl groupDaytime testingInterview criteriaStudy participantsMatched-groups designSleep labPolysomnographSufferersSleep settingsSuch testingModest differencesCurrent studyParticipantsIs This Woman Perimenopausal?
Bastian LA, Smith CM, Nanda K. Is This Woman Perimenopausal? JAMA 2003, 289: 895-902. PMID: 12588275, DOI: 10.1001/jama.289.7.895.Peer-Reviewed Original ResearchConceptsHigh follicle-stimulating hormone levelsGreatest positive likelihood ratioLower inhibin B levelsFollicle-stimulating hormone levelsMonths of amenorrheaPremenopausal control groupInhibin B levelsClinical examination findingsEnglish-language articlesPositive likelihood ratioNight sweatsVaginal drynessClimacteric symptomsPerimenopausal womenExamination findingsHot flashesMenstrual historyClinical examinationPerimenopausal statusHormone levelsMEDLINE searchWomen's agePerimenopauseControl groupSymptoms
2002
Hormone replacement therapy and the risk of death from breast cancer: A systematic review
Nanda K, Bastian LA, Schulz K. Hormone replacement therapy and the risk of death from breast cancer: A systematic review. American Journal Of Obstetrics And Gynecology 2002, 186: 325-334. PMID: 11854659, DOI: 10.1067/mob.2002.121077.Peer-Reviewed Original ResearchConceptsHormone replacement therapy usersHormone replacement therapyRisk of deathReplacement therapyBreast cancerTherapy usersCombined hormone replacement therapyRetrievable risk estimatesBreast cancer deathsCase-control studyRecency of useAscertainment of exposurePotential confoundersCancer deathRelative riskInclusion criteriaObservational studyHistologic conditionControl groupSystematic reviewProlonged durationTherapyProlonged useCancerRisk estimates